Resmed Inc. buy CLSA
Start price
02.09.25
/
50%
€232.70
Target price
02.09.26
-
Performance (%)
-7.43%
Price
15.12.25
€215.40
Summary
This prediction is currently active. With a performance of -7.43%, the BUY prediction for Resmed Inc. by CLSA is down slightly. This prediction currently runs until 02.09.26. The prediction end date can be changed by CLSA at any time. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.233% | 0.233% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by CLSA for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at CLSA from a "hold" rating to an "outperform" rating.
Ratings data for RMD provided by MarketBeat